The protective effects of temporary immunity under imposed infection pressure  by Swart, A.N. et al.
TA
a
b
c
d
a
A
R
R
A
A
K
C
I
S
I
i
b
s
u
i
r
t
c
d
m
p
M
s
e
r
1
dEpidemics 4 (2012) 43–47
Contents lists available at SciVerse ScienceDirect
Epidemics
journa l homepage: www.e lsev ier .com/ locate /ep idemics
he protective effects of temporary immunity under imposed infection pressure
.N. Swarta,∗, M. Tomasid, M. Kretzschmara,b, A.H. Havelaara,c, O. Diekmannd
National Institute of Public Health and The Environment, Bilthoven, The Netherlands
Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands
Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
Department of Mathematics, Utrecht University, Utrecht, The Netherlands
r t i c l e i n f o
rticle history:
eceived 5 August 2011
eceived in revised form 4 November 2011
ccepted 22 December 2011
vailable online 2 January 2012
eywords:
a b s t r a c t
The aim of this paper is to show in explicit detail that, due to the effects of waning and boosting of
immunity, an increasing force of infection does not necessarily lead to an increase in the incidence of
disease. Under certain conditions, a decrease of the force of infection may in fact lead to an increase of the
incidence of disease. Thus we conﬁrm and reinforce the conclusions from Águas et al. (2006), concerning
pertussis.We do so, however, in the context of Campylobacter infections in humans deriving from animal
reservoirs.ampylobacter
mmunity
IR-type model
For such an externally ‘driven’ epidemic we can ignore the transmission feedback cycle and treat the
force of infection as a parameter. As this parameter is, to a certain extent, under public health control, our
ﬁndings constitute an important warning: reducing exposure may not necessarily lead to a reduction in
the occurrence of clinical illness.
In a second part of the paper we relate the model parameters to the available data concerning campy-
lobacteriosis.
© 2012 Elsevier B.V. All rights reserved.ntroduction
For many infectious diseases, the beneﬁt of becoming infected
s in subsequent immunity. When immunity is waning, it may be
oosted again by reinfection, usually entailing little or no clinical
ymptoms. The aim of the present paper is to investigate such sit-
ations in the simplest conceivable setting, viz., when the force of
nfection is considered as a given constant, a parameter, rather than
esulting from a dynamic feedback loop. A concrete ’realization’ of
his setting is found when we look at foodborne diseases, such as
ampylobacteriosis and salmonellosis. Here, the force of infection
erives frombacterial growth in animal reservoirswhich are trans-
itted to humans by a myriad of pathways, with meat and other
roducts of animal origin as the dominant pathways.
odel assumptions
We shall adopt a caricatural description of the diverse immune
tatuses that an individual humanhost canhave. In factwe consider
xactly three possibilities, denoted by S, P and Q corresponding to,
espectively, susceptible, fully protected and partially protected.
∗ Corresponding author. Tel.: +31 0 30 274 7004.
E-mail address: arno.swart@rivm.nl (A.N. Swart).
755-4365/$ – see front matter © 2012 Elsevier B.V. All rights reserved.
oi:10.1016/j.epidem.2011.12.002In order to avoid confusion, we ﬁrst deﬁne the various stages of
pathogenesis thatmayarise. An individual is exposedwhenamicro-
organism enters the host. In our case study concerning foodborne
campylobacteriosis, one can think of exposure as consumption of a
contaminated food product. After exposure, infection may occur. In
this state the micro-organism has settled in the host (e.g. Campy-
lobacter starts multiplying in the gastro-intestinal tract). When
infected, a susceptible becomes fully protected against re-infection.
We assume that the time span between exposure and infection is
negligible (in the order of days, Black et al. (1988), which is small
on the time scale of interest – the life span of the human host) and
workwith a force of infection for S→P transitions. After infection,
an individual may or may not develop illness, which is a symp-
tomatic response to infection. We shall capture the quantitative
aspects by postulating that illness occurs with a certain probability
. Note that our term infection amounts to symptomatic or asymp-
tomatic infection, depending on whether illness occurs or not (so in,
respectively, a fraction  and a fraction 1− of all cases).
Thewaning of immunity is represented by P→Q andQ→ S tran-
sitions.Weassume that sojourn timesareexponentiallydistributed
and,moreprecisely, that the transition P→Qoccurswith rate˛ and
the transition Q→ S with rate  .When a fully protected individual is exposed, nothing happens,
i.e., the individual does not become re-infected and the immune
status does not change. When, on the other hand, a partially pro-
tected individual is exposed (which happens with rate ), the
44 A.N. Swart et al. / Epidemics 4 (2012) 43–47
the in
i
s
a
F
s
a
t
n
s
e
T
t
t
v
a
s
v
M
p
b
a
o
R
I
b
p
w
M
s⎧⎪⎨
⎪⎩Fig. 1. Schematic overview of
ndividual does not become ill. Instead, the individual’s immune
tatus is instantaneously boosted to full protection. The mech-
nisms postulated in this section are schematically depicted in
ig. 1.
Now consider a newborn individual. It will make the S→P tran-
ition a number of times, before ultimately dying (note that we
ssume that illness is ‘harmless’ in the sense that there is no mor-
ality associatedwith it).We denote the expectation of this random
umber by R. Clearly R depends on the parameters , ˛,  and the
urvival process. In the next section we shall derive an explicit
xpression for R and study the dependence on these parameters.
he underlying idea is that R captures how much of a nuisance
he disease is, because the expected number of times an individual
urns ill equals the product of  and R. As one may inﬂuence the
alue of  by enforcing various regulations onto the food industry,
relevant question iswhether R increases proportionallywith , or
hows non-linear behavior, possibly exhibiting localmaximawhen
iewed as a function of .
athematical analysis of the model
Let the age of an individual be denoted by a. We introduce the
robability F(a) to survive until at least age a. Let s(a) be the proba-
ility that a living individual is susceptible at age a. Then, since by
ssumption changes in the immune status do not have any impact
n survival,
= 
∫ +∞
0
s(a)F(a)da. (1)
t remains to calculate s(a). To do so, we ﬁrst introduce the proba-
ilities p(a) and q(a) that at age a the individual is fully or partially
rotected. The model assumptions imply that
d
da
⎛
⎜⎝
s
p
q
⎞
⎟⎠ = M
⎛
⎜⎝
s
p
q
⎞
⎟⎠ , (2)
here the matrix M is given by
=
⎛
⎜⎝
− 0 
 −˛ 
0 ˛ −( + )
⎞
⎟⎠ .
As we assume that individuals are born susceptible, the corre-
ponding initial conditions reads(0) = 1,
p(0) = 0,
q(0) = 0.
(3)fection and immunity process.
By computing eigenvalues and eigenvectors of M, we construct the
explicit solution, assuming that ˛ /=  ,
⎛
⎜⎝
s(a)
p(a)
q(a)
⎞
⎟⎠ = 1(˛ + )( + )
⎛
⎜⎝
˛
( + )
˛
⎞
⎟⎠
+ 
(˛ − )(˛ + )
⎛
⎜⎝
−
 − ˛
˛
⎞
⎟⎠ e−(˛+)a
+ ˛
(˛ − )( + )
⎛
⎜⎝
1
0
−1
⎞
⎟⎠ e−(+)a. (4)
The quantity s(a), relevant for calculation of R, may be written
as
s(a) = ˛(˛ + )e
−(+)a − ( + )e−(˛+)a + ˛(˛ − )
(˛ + )( + )(˛ − )
In order tomake further progresswe need to specify F(a). A familiar
choice is the exponential survival function
Fe(a) = exp
(
− a
A
)
, (5)
where A corresponds to the expected length of life. We ﬁnd
Re = A A + (1 + A)(1 + ˛A)(1 + A + A)(1 + A + ˛A) , (6)
The alternative
Fu(a) =
{
1, 0 ≤ a ≤ A,
0, a > A,
(7)
corresponding to guaranteed survival till age A and certain death
at that age, leads to
Ru = ˛A(˛ + )( + ) +
˛2
(˛ − )( + )2
(1 − e−(+)A)
− 
2
(˛ − )(˛ + )2
(1 − e−(˛+)A). (8)
Even though suchuniformsurvival is a caricature, it captures the
situation in industrialized countries much better than exponential
survival does.
We now investigate how R (in the following R stands for both
Ru and Re) depends on . Clearly Re =Ru =0 for =0, both increase
for small  and both tend to one for  tending to inﬁnity. One can
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erify by asymptotic expansion that Ru decreases towards its limit
at inﬁnity. By examining the derivate of Re with respect to , one
erives that there is exactly one maximum when ˛A2 >1 and that
e is monotone increasing for ˛A2 ≤1. For Ru we did not manage
o show the existence of a single global maximum analytically, but
xtensive numerical search did not produce a single example with
ore than one maximum.
Thus there exists, under assumptions which are met in practice
see Section 4), a range of values of  where an increase in  results
n a decrease in R and, hence, a decrease in  results in an increase
f R.
We found that the results for both expressions of R are very
imilar. There is a natural explanation for this observation. Consid-
ring that the age A is large compared to the other parameters in
hemodel, onemay examine expressions (6) and (8). Scaled by A, in
he asymptotic approximation for A→∞, both expressions become
dentical,
Ra
A
:= lim
A→∞
Re
A
= lim
A→∞
Ru
A
= ˛
(˛ + )( + ) , (9)
here the index a indicates that the result is asymptotic. Note that
a is linear in A. Furthermore, in
A
Ra
= 1

+ ˛ +  + 
˛
,
he right hand side can be interpreted as the expected time needed
or a round trip from S to S. To see this, ﬁrst deﬁne T as the expected
ime needed for the transition from P to S conditional on not dying.
hen T satisﬁes
= 1
˛
+ 
 + 
1
 +  +

 + 
[
1
 +  + T
]
.
ndeed, after an expected time of 1/˛ the transition P→Q is made;
ubsequently with probability /( +) the transition Q→ S is
ade,whilewith thecomplementaryprobability/( +) return to
occurs; the expected sojourn time in Q is 1/( +). It follows that
= (˛+ +)/˛ . To obtain the expected time needed for a round
rip from S to S we have to add to T the expected time 1/ involved
n the transition S→P.
We conclude that the number of infections in a lifetime is
oughly the life expectancy over the time needed for a S→ S transi-
ion. The simpleexpression forRa alsoenablesus towrite a tractable
xpression for its single globalmaximum, and the force of infection
t which it occurs,
a,max = A
(˛−1/2 + −1/2)2
, (10)
a,max =
√
˛. (11)
ince in practice the results forRu,Re andRa were indistinguishable,
e will work with the simpler expression for Ra in the remainder.
ampylobacter case study
In the following, we treat campylobacteriosis as an example.
his example is particularly suitable for the current model, as
here are strong indications for the existence of protective tem-
orary immunity. The evidence is summarized in Havelaar et al.
2009), and includes serological studies, data from surveillance and
utbreaks, and analysis of travel-induced illness. Furthermore evi-
ence is presented for frequent re-infections lacking clinical signs.
erhaps most convincing in exposing the difference in protection
rom infection and illness is the data from Tribble et al. (2010)
iscussed below.
In principle one could consider a more complex ﬂow chart
han the one depicted in Fig. 1, incorporating, for instance, directics 4 (2012) 43–47 45
transitions from P back to S. This then introduces additional param-
eters and in view of the difﬁculty of estimating parameters we
choose not to do this. Note, moreover, that the sojourn time of an
individual in Q may be short by chance, especially when  is large.
The parameter is a summary statistic. Underlying components
are the dose distribution as well as the dose–response relation
(Teunis et al., 1999). In experiments one usually applies a standard-
ized and high dose. We provide  with an index c (for ‘conditioned
on high dose’) when dealing with data obtained in such exper-
iments. Please note that an estimate of c provides hardly any
information about .
Maximum likelihood estimates ˆ˛ , ˆ and ˆc for ˛,  and c are
derived from Tribble et al. (2010), who report results of experi-
mental infection in humans. Volunteers were exposed to a single
strain of Campylobacter jejuni in doses ranging between 105 and
109 cfu. From the individuals who received a dose of 109, two dis-
joint groupswere re-challenged, one after 28–49days andone after
1 year, with the same dose. Let f(k, n, p) denote the probabilitymass
function for the binomial distribution with k successes out of n,
with a probability p of success. At ﬁrst exposure all volunteerswere
infected, which we interpret as having made a S→P transition. Ill-
ness occurred in 33 of 36 volunteers, which implies a contribution
l1 = f (33,36,c)
to the likelihood function. We learn that re-exposure at (on aver-
age)day38 resulted in re-infectionof 6of the8volunteers. Basedon
the fact that none of the eight volunteers became ill, and that Q→ S
transitions occur on average on a longer time scale, we assume that
no Q→ S transitions took place. Of course there is still a small prob-
ability of a Q→ S transition followed by asymptomatic infection,
but we neglect this effect since the impact on the parameter esti-
mateswill beminimal. Given 100% infection of the naive subjects at
a dose of 109 cfu we also assume that re-exposure of an individual
in Q to the same dose always leads to infection. In order to become
infected, an individualmust have been in theQ compartment. Thus,
6 out of 8 have made a P→Q transition within 38 days, and were
subsequently infected. Using the cumulative density function for
exponential residence time in the P compartment, we obtain the
following contribution to the likelihood
l2 = f (6,8,1 − exp(−˛38/365)).
Fromthe samepaper,we learn thathomologous re-exposureafter1
year results in illness in4of the7volunteers. Illness is only achieved
coming from the S compartment. We interpret this as 4 out of 7
subjects having made the P→Q→ S transition, followed by illness,
within one year. It is a simple matter to calculate the cumulative
probability density function for the sum of the exponential waiting
times in P and Q,
G(t) = 1 − 1
 − ˛
[
e−˛t − ˛e−t
]
.
Using this function, we have the following contribution to the like-
lihood,
l3 = f (4,7,cG(1)).
Maximizing the complete likelihood function l= l1l2l3 yields the
MLE estimates for the parameters. We ﬁnd ˆ˛ ≈ 13.0 per year,
ˆ ≈ 1.1 per year and ˆc ≈ 0.92. In other words, the average res-
idence time is about 1 year in the Q compartment and about 26
days in the P compartment. The estimate for c obtained here is
not very useful in practice, since usually exposure to Campylobac-
ter is at very low dose. The estimates for ˛ and  , however, we
consider dose-independent, and representative for any individual.
46 A.N. Swart et al. / Epidem
Fig. 2. The number of infections per lifetime, as a function of the force of infection.
The three bands correspond to ˛= (6.5, 13, 26). The three curves in each a band
represent  = (0.5, 1.0, 2.0). Those values were chosen to represent uncertainty in
parameter estimates. The setting (˛, ) = (13, 1.0) is our point estimate and indicated
by a thick curve. Within each band the maximum of the number of infections Ra,max
and the max at which they occur are indicated by dots. Dashed and solid lines were
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rdded for visual aid. The typical force of infection of =1 and the corresponding Ra
re indicated by a large dot.
From (Evers et al., 2008) we learn that, on average, exposure to
ampylobacter is 1 cfu per week. Furthermore, (Evers et al., 2008)
nd (Nauta et al., 2007) suggest that the greatmajority of exposures
s at very low doses. Therefore, we use the linear approximation
o the dose–response relation and use a single-hit probability of
nfection of 0.02 (Teunis and Havelaar, 2002; Havelaar et al., 2009).
rom this we ﬁnd  is in the order of 1 per year. This estimate is
onsistent with the ﬁndings of (Havelaar et al., 2009) and (Teunis
t al., in press) who also arrive at a ﬁgure of 1 infection per year.
Fig. 2 shows the number of infections per lifetime as a function
f . Thus, we ﬁnd for ≈1 about 37 infections in a lifetime. A
aximum of Ra,max ≈49 is found when max ≈3.6. Here we chose a
aximum age of A=80, which is representative for industrialized
ountries (WHO, 2010). For low-income countries, one would set
=50, which is typical for countries in tropical Africa (WHO, 2010).
hoosing =10 yields Ra ≈26 infections per lifetime.
In termsof age-dependentdynamicsof immunestatus, there are
triking differences between industrialized and low-income coun-
ries (Fig. 3). The fractions in the various compartments stabilize
lreadyat youngage, but equilibrium is reachedmuch faster in low-
ncome countries (at about one year of age) than in industrialized
ounties (at about 3 years of age). In equilibrium we ﬁnd fractions
n S, P and Q of 0.48, 0.07 and 0.45 respectively for industrialized
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countries. In stark contrast, for low-income countries these frac-
tions are 0.05, 0.43 and 0.52. These susceptible and fully protected
fractions have virtually switched places.
Discussion
Our results may be compared to the model results of (Águas
et al., 2006) for Bordetella pertussis. The authors also present a com-
partmental model including waning of immunity and ﬁnd that
disease incidence peaks at intermediate values of the infection
pressure.
In (Nagao and Koelle, 2008) a model for dengue fever incidence
in the presence of (cross-)immunity was developed. These authors
conclude that amoderate reduction of transmissibility (in the guise
of the basic reproduction number R0) may actually increase inci-
dence. Also, similar to the results of our analysis, they show that
the dependence of incidence on transmissibility is non-monotonic.
A signiﬁcant decrease of R0 will in the end have a beneﬁcial effect.
McBride and French (2006) have proposed a model including
waning of immunity and symptomatic (but not asymptomatic)
Campylobacter infection which is very close to ours. If in Fig. 1 we
would let the arrow out of S with weight (1−) end in Q (so if
there is no illness an individual skips the P state) and eliminate the
arrow with weight  fromQ back to P, we obtain their model, albeit
with a difference in interpretation. Namely, in their setting P corre-
sponds to ‘infected, accompanied by illness’ (which does matter if
data are used to estimate parameters!). They restrict their analysis
to exponential survival (5). Their main result is that the probabil-
ity to be ‘infected, accompanied by illness’ peaks as a function of
age. In another study, (Brunham et al., 2005) present a mathemat-
ical model for Chlamydia trachomatis infection which also includes
immune compartments. They ﬁnd that interventionmeasures aim-
ing at reducing the infectious period may lead to an increase in
prevalence in the long run.
Even for our model with only four parameters, estimates were
difﬁcult to ﬁnd. There is only one published challenge–rechallenge
study, with limited group sizes. Nevertheless, this study provides
data that allow the most direct estimates of the duration of protec-
tive immunity.
Our parameter estimates suggest that in industrialized coun-
tries the force of infection will be below the value at which a
maximum of Ra is attained. Hence, reducing the force of infection is
expected to lead to a reduction in the incidence of illness, although
not necessarily in a proportionalway.We note, however, that thereals in industrialized countries (farmers, slaughterhouse workers,
veterinarians) may undergo much higher exposure levels than the
average individual.
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We ﬁnd that the prevalence of fully protected individuals rises
uickly with age to about 7%. Havelaar et al. (2009) report that
he prevalence of asymptomatic excretion of Campylobacter in the
etherlands was 0.6%, about a 10-fold difference with the max-
mum of P. This may be explained by noting that full protection
asts longer than infection, which in turn typically lasts longer than
etectable excretion of bacteria.
Ourmodel suggests that a great numberof infections are asymp-
omatic. This ﬁnding is backed up by the results ofAng et al. (2011),
ho study Campylobacter speciﬁc antibody levels in sera of the
utch general population. They ﬁnd that seroprevalence increases
teadily with age, reaching 100% at an age of 20, implying frequent
symptomatic infections throughout life.
Illness is estimated to occur once every 200 years (Havelaar
t al., 2009). Given our result ofRa =37 asymptomatic infections per
ifetime this would yield the estimate  ≈1.1×10−2. In (Havelaar
t al., 2009) it is further stated that about 1% of infections is fol-
owed by illness, thus,  ≈1×10−2, which concurs very well with
ur estimate. In volunteer experiments, where doses are typically
n the range of 105 to 109 cfu, very high values for c are found, in
he order of 1/3 (Black et al., 1988) to 0.9 (Tribble et al., 2010). Thus,
he probability that exposure leads to illness appears to be strongly
ose-dependent and further modeling efforts should focus on the
nclusion of dose–response relationships in the force of infection.
In low-income countries the force of infection is higher than
n industrialized countries (Havelaar et al., 2009; Blaser, 1998),
ost kids having been infected by the age of two. An estimate
f  is hard to obtain from the available literature. Speciﬁc esti-
ates of ˛ and  for low-income countries are not available. We
se the values obtained for industrialized countries, and assume
=10. At such values, the force of infection is well above max,
nd our model suggests that lowering the force of infection may
ell lead to an increase of human illness. This hypothesis is sup-
orted by the results of (Oberhelman et al., 2006), who found
hat corralling of free-ranging chickens in Peruvian shanty-town
ouseholds resulted in signiﬁcantly higher rates of Campylobacter-
elated diarrhea than in controls. Rates of asymptomatic excretion
f Campylobacter were similar in the intervention and control
roups. The incidence of infection among young children in low-
ncome countries is estimated by (Valentiner-Branth et al., 2003)
o be 0.35 per year, and cited in (Havelaar et al., 2009) to be at
ost 1 episode per year. Again, this is in agreement with our result
Ra ≈26, 26/50≈0.55). In general, illness is associatedwith the very
oung, while infection rates remain high for all ages. An effect like
his may be observed in the right panel of Fig. 3 where the number
f susceptibles declines very rapidly, settling at 0.05 at about half
year of age. The proportion in Q, those who may get infected but
ill not experience illness, is over 50%.
The ﬁndings of this paper are also of relevance for quantita-ive microbiological risk assessments (QMRA). Typically, such risk
ssessments model probabilities of exposure and dose distribu-
ions. Immunity effects however, are usually not incorporated – the
isk of illness given exposure is not dependent on past exposures.ics 4 (2012) 43–47 47
Incorporating immunity effects into QMRA models would reduce
thenumberof calculated cases of infectionor illness. Thismaybring
QMRAestimatesmore in linewith epidemiological estimates, since
QMRAs typically tend to overestimate disease incidence.
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